FindMyKOL
Clinical trialNCT01406821CompletedInterventional

Treatment of Acute and Chronic Ligament and Tendon Injuries With Platelet Rich Plasma

NCT01406821 is an interventional trial sponsored by Stanford University. As of 21 Nov 2026, it is completed. It studies Tendinopathy. The registry lists an enrollment of 30 participants at 2 sites in 1 country. The registry lists a start date of 31 Aug 2009 and a primary completion date of 15 Mar 2019.

SponsorStanford University →Enrollment30Tendinopathy
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT01406821
FieldValue
Registry IDNCT01406821
StatusCompleted
Study typeInterventional trial
Lead sponsorStanford University
Enrollment30
Registered sites2
Countries1
ConditionsTendinopathy
Start31 Aug 2009
Primary completion15 Mar 2019
Study completion15 Mar 2019
Last update posted29 Mar 2019

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Platelet rich plasma has been used in previous studies to stimulate faster healing of torn ligaments and tendons in order to help reduce pain and restore normal function. This study aims to prove that non-operative treatment of acute and chronic ligament and tendon injuries with platelet rich plasma will reduce the time needed for participants to heal these injuries and restore function. We are currently enrolling patients with PATELLAR TENDON INJURIES in the KNEE.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

California, United States1 site
  • Stanford University School of Medicine

    Stanford

New York, United States1 site
  • New York University Langone Orthopedic Hospital

    New York

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew York: 1 siteNY1MassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCalifornia: 1 siteCA1NevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT01406821

Each answer restates registry values shown on this page.

What is NCT01406821?

NCT01406821 is an interventional trial sponsored by Stanford University. It studies Tendinopathy.

Who leads NCT01406821?

The registry names Dr. Christina Herrero (study director, New York University Langone Orthopedic Hospital) and Dr. Jason L. Dragoo (principal investigator, Stanford University) as overall officials.

Where does NCT01406821 run?

The registry lists 2 sites in 1 country. Every site with a stated country is in one country: United States.

When did NCT01406821 end?

The registry lists a primary completion date of 15 Mar 2019 and a study completion date of 15 Mar 2019. The sponsor last updated the record on 29 Mar 2019.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.